Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Milestone Scientific Inc commences sales of CompuFlo Epidural disposables at two surgery centers in California

Both of these prominent pain management practices are owned by Pain Management Specialists (PMS), a group of specially trained physicians, dedicated to the evaluation and treatment of acute and chronic pain

Milestone Scientific Inc (NYSE:MLSS) said that it has commenced sales of the CompuFlo Epidural disposables at the Cypress Surgery Center in Santa Maria, California and the Galileo Surgery Center in San Luis Obispo.

Both of these prominent pain management practices are located in California and owned by Pain Management Specialists (PMS), a group of specially trained physicians, dedicated to the evaluation and treatment of acute and chronic pain.

Its physicians utilize the latest techniques and apply the most current theories, to provide patients with a comprehensive treatment plan, necessary to assist in their fight against pain.

In a statement, Arjan Haverhals, CEO and president of Milestone Scientific, commented: "We continue to expand sales of our CompuFlo Epidural system within pain clinics across the US. The selection of our technology by these two clinics follows successful evaluation, reinforcing the safety, economic and efficiency benefits, as well as the improved patient experience."

READ: Milestone Scientific projects 85% rise in 2021 revenue to more than $10M as divisions gain traction

Milestone Scientific is a technology-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications.

The company's computer-controlled systems are designed to make injections precise, efficient and increase overall patient comfort and safety. Its proprietary DPS Dynamic Pressure Sensing Technology instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic.

Contact the author at jon.hopkins@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK